North Star Investment Management Corp. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,784
-66.3%
4,4000.0%0.00%
-66.7%
Q2 2023$109,296
+65.2%
4,4000.0%0.01%
+80.0%
Q1 2023$66,176
+27.1%
4,4000.0%0.01%0.0%
Q4 2022$52,052
+100.2%
4,4000.0%0.01%
+66.7%
Q3 2022$26,000
+36.8%
4,4000.0%0.00%
+50.0%
Q2 2022$19,000
-93.2%
4,400
-85.0%
0.00%
-90.9%
Q1 2022$280,000
+330.8%
29,400
+764.7%
0.02%
+340.0%
Q4 2021$65,000
-42.5%
3,4000.0%0.01%
-44.4%
Q3 2021$113,000
-45.4%
3,400
-83.8%
0.01%
-71.0%
Q1 2020$207,000
-11.2%
21,0000.0%0.03%
+29.2%
Q4 2019$233,000
+97.5%
21,0000.0%0.02%
+84.6%
Q3 2019$118,000
-35.2%
21,0000.0%0.01%
-38.1%
Q2 2019$182,000
+7.7%
21,0000.0%0.02%
+5.0%
Q1 2019$169,000
+96.5%
21,0000.0%0.02%
+81.8%
Q4 2018$86,000
-27.1%
21,0000.0%0.01%
-15.4%
Q3 2018$118,000
-57.2%
21,0000.0%0.01%
-59.4%
Q2 2018$276,000
-7.4%
21,0000.0%0.03%
-11.1%
Q1 2018$298,000
+73.3%
21,0000.0%0.04%
+71.4%
Q4 2017$172,000
-30.9%
21,0000.0%0.02%
-34.4%
Q3 2017$249,000
+18.0%
21,0000.0%0.03%
+14.3%
Q2 2017$211,000
-13.9%
21,0000.0%0.03%
-17.6%
Q1 2017$245,000
+432.6%
21,000
+110.0%
0.03%
+385.7%
Q4 2016$46,00010,0000.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders